Several people shared their experiences Wednesday at the Alzheimer's Foundation of America's tour stop in Little Rock. The ...

Although Axsome is benefiting from Auvelity’s momentum and its broader commercial portfolio, the CNS space remains highly ...

A little-known treatment for heart failure, developed more than half a century ago and refined in the '70s, may have legs as a potential therapy for Alzheimer's patients.

The memory-care unit wants to calm Mom down with a pill. Before you say yes, there's something they may have skipped.

New research links repeated gabapentin use with increased risk, prompting cautious monitoring for gabapentin and dementia ...

Biogen's Q3 earnings are due Oct 28. Explore FY2026 EPS guidance, Alzheimer’s revenue growth, and key risk/reward ...

Spread the loveImagine a world where an Alzheimer’s diagnosis doesn’t automatically mean an inevitable, rapid decline.

Arrowhead Pharmaceuticals, Inc. beats on ARO-MAPT with up to 85% CSF tau cut; CNS siRNA platform gains traction. Click for ...

The Cystic Fibrosis Foundation acknowledged the essential role of the NIH in a 2025 letter to Russell Vought and other Trump administration leaders, writing that “ensuring that the National Institutes ...

The third quarter of 2026 was the busiest of the year so far in terms of novel FDA drug approvals, with a total of 22 (Table 1) — well ahead of both the 13 approvals in the second quarter and the ...

The medical marijuana competitive landscape report delivers important insights into approved as well as ongoing research of 65+ pipeline medical marijuana drugs, clinical strategies, upcoming ...